Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 10:33 PM
Ignite Modification Date:
2025-12-25 @ 8:05 PM
NCT ID:
NCT01110135
Group ID:
EG000
Title:
Treatment (Chemotherapy and Colony-stimulating Factor)
Description:
Patients receive bendamustine hydrochloride IV over 30-60 minutes on days 1 and 2, etoposide IV over 60-240 minutes on days 1-3, dexamethasone PO on days 1-4, and filgrastim SC beginning on day 5 and continuing until peripheral blood stem cell collection is complete. Patients undergo leukapheresis daily for a minimum of 3 days or until \> 5 x 10\^6 CD34+/kg has been collected.
.
bendamustine hydrochloride: Given IV
dexamethasone: Given PO
filgrastim: Given SC
leukapheresis: Given IV
laboratory biomarker analysis: Correlative studies
flow cytometry: Correlative studies
etoposide: Given IV
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
6
Serious Number At Risk:
34
Other Number Affected:
34
Other Number At Risk:
34
Study:
NCT01110135
Results Section:
NCT01110135
Adverse Events Module:
NCT01110135